Theo Karapanagiotidis

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.

Journal: Vaccine

Published: December 14, 2025

Alternative treponemal serology assays for diagnosis and confirmation of syphilis in a diagnostic laboratory: a retrospective evaluation of four agglutination assays and one ELISA.

Alternative treponemal serology assays for diagnosis and confirmation of syphilis in a diagnostic laboratory: a retrospective evaluation of four agglutination assays and one ELISA.

Journal: Journal of clinical microbiology

Published: May 09, 2025

Single-cell immune profiling of third trimester pregnancies defines importance of chemokine receptors and prevalence of CMV-induced NK cells in the periphery and decidua.

Single-cell immune profiling of third trimester pregnancies defines importance of chemokine receptors and prevalence of CMV-induced NK cells in the periphery and decidua.

Journal: medRxiv : the preprint server for health sciences

Published: April 08, 2025

Prevalence of Murray Valley encephalitis virus antibodies in northern Victoria following the 2023 outbreak: a cross-sectional serological survey.

Prevalence of Murray Valley encephalitis virus antibodies in northern Victoria following the 2023 outbreak: a cross-sectional serological survey.

Journal: Communicable diseases intelligence (2018)

Published: March 24, 2025

Differential COVID-19 case ascertainment by age and vaccination status in Victoria, Australia: a serosurveillance and record linkage study.

Differential COVID-19 case ascertainment by age and vaccination status in Victoria, Australia: a serosurveillance and record linkage study.

Journal: Communicable diseases intelligence (2018)

Published: August 21, 2024

The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional study.

The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional study.

Journal: PloS one

Published: February 29, 2024

Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study.

Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study.

Journal: The Medical journal of Australia

Published: September 01, 2023

Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab.

Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab.

Journal: Open forum infectious diseases

Published: August 11, 2023

Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan.

Newborn and child-like molecular signatures in older adults stem from TCR shifts across human lifespan.

Journal: Nature immunology

Published: March 24, 2023

Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapy.

Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapy.

Journal: EJHaem

Published: December 20, 2022

Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells.

Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells.

Journal: Cell reports. Medicine

Published: November 03, 2022

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.

Journal: Open forum infectious diseases

Published: January 15, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026